These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 33204160)

  • 1. miR-105 Promotes the Progression and Predicts the Prognosis for Oral Squamous Cell Carcinoma (OSCC).
    Zhang HY; Ma JH
    Cancer Manag Res; 2020; 12():11491-11499. PubMed ID: 33204160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-183-5p Promotes Tumor Progression of Osteosarcoma and Predicts Poor Prognosis in Patients.
    Jin L; Luo Y; Zhao YC; Tao H
    Cancer Manag Res; 2021; 13():805-814. PubMed ID: 33536788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-155-5p promotes oral cancer progression by targeting chromatin remodeling gene ARID2.
    Wu M; Duan Q; Liu X; Zhang P; Fu Y; Zhang Z; Liu L; Cheng J; Jiang H
    Biomed Pharmacother; 2020 Feb; 122():109696. PubMed ID: 31918270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor expression of miR-448 is a prognostic marker in oral squamous cell carcinoma.
    Wei H; Yu K; Liu Y; Li L; Wang G
    BMC Cancer; 2020 Aug; 20(1):756. PubMed ID: 32787801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of lncRNA FEZF1-AS1 in promoting the occurrence and development of oral squamous cell carcinoma through targeting miR-196a.
    Xu L; Hou TJ; Yang P
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6505-6515. PubMed ID: 31378890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-222-3p participates in the development of oral squamous cell carcinoma by targeting CDKN1B.
    Yang K; Chen Y; Cui Z; Chen H; Yang L; Zhao J; Luo F; Man S; Zhao J; Jin L
    J Oral Pathol Med; 2020 Aug; 49(7):621-629. PubMed ID: 31841247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-758-3p Inhibits Proliferation, Migration, and Invasion of Clear Cell Renal Cell Carcinoma and Predicts Favorable Prognosis.
    Wu Y; Liu Y
    Cancer Manag Res; 2020; 12():9285-9295. PubMed ID: 33061618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosome-derived microRNAs in oral squamous cell carcinomas impact disease prognosis.
    Chen CM; Chu TH; Chou CC; Chien CY; Wang JS; Huang CC
    Oral Oncol; 2021 Sep; 120():105402. PubMed ID: 34174519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-610 functions as a tumor suppressor in oral squamous cell carcinoma by directly targeting AGK.
    Yao LX; Liu J; Xu L
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):187-197. PubMed ID: 30657560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-23a-3p suppresses cell proliferation in oral squamous cell carcinomas by targeting FGF2 and correlates with a better prognosis: miR-23a-3p inhibits OSCC growth by targeting FGF2.
    Chen F; Qi S; Zhang X; Wu J; Yang X; Wang R
    Pathol Res Pract; 2019 Apr; 215(4):660-667. PubMed ID: 30606659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LINC00152 promotes the growth and invasion of oral squamous cell carcinoma by regulating miR-139-5p.
    Li M; Ning J; Li Z; Wang J; Zhao C; Wang L
    Onco Targets Ther; 2018; 11():6295-6304. PubMed ID: 30310293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-146a Overexpression in Oral Squamous Cell Carcinoma Potentiates Cancer Cell Migration and Invasion Possibly
    Wang L; Chen Y; Yan Y; Guo X; Fang Y; Su Y; Wang L; Pathak JL; Ge L
    Front Oncol; 2020; 10():585976. PubMed ID: 33282738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-150 suppressed cell viability, invasion and EMT via HMGA2 in oral squamous cell carcinoma.
    Liu DK; Yu S; Li JP; Song WW; Li JH
    Eur Rev Med Pharmacol Sci; 2021 Jun; 25(11):3981-3989. PubMed ID: 34156675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of miR-1269 Contributes to the Progression of Esophageal Squamous Cell Cancer Cells and Is Associated With Poor Prognosis.
    Bai X; Wang Q; Rui X; Li X; Wang X
    Technol Cancer Res Treat; 2021; 20():1533033820985858. PubMed ID: 33416035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA PVT1 promotes tumor cell proliferation, invasion, migration and inhibits apoptosis in oral squamous cell carcinoma by regulating miR‑150‑5p/GLUT‑1.
    Li X; Ren H
    Oncol Rep; 2020 Oct; 44(4):1524-1538. PubMed ID: 32945498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of miR-133b indicates poor prognosis and promotes progression of OSCC via SOX4.
    Yang J; Wang H; Xu W; Chen Z; Yan ZY; Zhang LJ
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12717-12726. PubMed ID: 33378019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
    Li GH; Ma ZH; Wang X
    Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.
    Xu H; Yang Y; Zhao H; Yang X; Luo Y; Ren Y; Liu W; Li N
    Tumour Biol; 2016 Jan; 37(1):447-53. PubMed ID: 26224475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-375 Inhibits Growth and Enhances Radiosensitivity in Oral Squamous Cell Carcinoma by Targeting Insulin Like Growth Factor 1 Receptor.
    Zhang B; Li Y; Hou D; Shi Q; Yang S; Li Q
    Cell Physiol Biochem; 2017; 42(5):2105-2117. PubMed ID: 28810236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-146a promotes proliferation, invasion, and epithelial-to-mesenchymal transition in oral squamous carcinoma cells.
    Wang F; Ye LJ; Wang FJ; Liu HF; Wang XL
    Environ Toxicol; 2020 Oct; 35(10):1050-1057. PubMed ID: 32469461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.